Skip to main content
Caplight Logo









Ergo Bioscience

Ergo Bioscience

Private
SunchalesHealthcare & Life Scienceshttps://www.ergobiotech.com/

Last Round

Seed

Oct 17, 2024

Total Funding Raised

$4.5M

Company Overview

Ergo Bioscience is a biotechnology company that develops plant-based protein ingredients using precision fermentation of plant cells to create realistic meat and dairy alternatives.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials, Fashion & Beauty, Clean Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

precision fermentationplant cell cultureanimal-free proteincellular agriculturerecombinant proteinsalternative proteinplant-based meatplant-based dairybiotechnology platformmolecular biologysynthetic biologyAI-driven biologyfood techingredient supplierbiotech R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ergo Bioscience Comparables

Compare Ergo Bioscience with similar companies based on industry and business-model similarity.

Ergo Bioscience comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Neoproteins
83%
Miruku
83%
Asterix Foods
80%

Ergo Bioscience Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 17, 2024
SeedSep 1, 2024
AcceleratorSep 19, 2023

Key People

Founding team and executive leadership

Augusto Desuque

Chief Technology Officer (CTO) Head Of Bioprocessing Co-founder, Chief Technology Officer (CTO) Head Of Bioprocessing Co-founder

Founding Team

Ergo Bioscience Investors

Notable investors and investment history

Ergo Bioscience investors
InvestorRounds
Eatable AdventuresAccelerator
CITESSeed, Accelerator
Ag-West Bio Inc.Seed
Pascual InnoventuresSeed, Accelerator
Global Agri-Food Advancement PartnershipSeed
ProVeg InternationalSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2024

    $2M raised from Pascual Innoventures and CITES.

  • Sep 19, 2023

    $500K raised from Eatable Adventures and others.

Ergo Bioscience Filings

Explore SEC and related filing metadata, where available.

Ergo Bioscience filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ergo Bioscience's valuation, stock price, and market status.

Is Ergo Bioscience a public or private company?

Ergo Bioscience is a private company.

What is the current stock price of Ergo Bioscience?

Ergo Bioscience is a private company with no public stock price. No recent secondary market data is available.

How much is Ergo Bioscience worth (valuation)?

Valuation information for Ergo Bioscience is not publicly available.

Can I buy Ergo Bioscience stock?

Ergo Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ergo Bioscience's last funding round?

Ergo Bioscience's most recent funding round was Seed on October 17, 2024.

Who are the main investors in Ergo Bioscience?

Key investors in Ergo Bioscience include Eatable Adventures, CITES, Pascual Innoventures, ProVeg International.

Will Ergo Bioscience IPO soon?

No public IPO plans have been announced for Ergo Bioscience.

How can I track Ergo Bioscience secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ergo Bioscience's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSunchales
Employee Range24
Year Founded2020
Last FundingOct 17, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?